Abstract
A fast‐gradient high‐performance liquid chromatographic (HPLC) method has been suggested to characterize the interactions of drugs with an immobilized artificial membrane (IAM). With a set of standards, the gradient retention times can be converted to Chromatographic Hydrophobicity Index values referring to IAM chromatography (CHIIAM) that approximates an acetonitrile concentration with which the equal distribution of compound can be achieved between the mobile phase and IAM. The CHIIAM values are more suitable for interlaboratory comparison and for high throughput screening of new molecular entities than the log kIAM values (isocratic retention factor on IAM). The fast‐gradient method has been validated against the isocratic log kIAM values using the linear free energy relationship solvation equations based on the data from 48 compounds. The compound set was selected to provide a wide range and the least cross‐correlation between the molecular descriptors in the solvation equation:(2)SP=c+r·R2+s·π2H+a·Σα2H+b·Σβ20+v·Vxwhere SP is a solute property (e.g., logarithm of partition coefficients, reversed‐phase (RP)‐HPLC retention parameters, such as log k, log kw, etc.) and the explanatory variables are solute descriptors as follows: R2 is an excess molar refraction that can be obtained from the measured refractive index of a compound, π2H is the solute dipolarity/polarizability, ∑α2H and ∑β20 are the solute overall or effective hydrogen‐bond acidity and basicity, respectively, and Vx is the McGowan characteristic volume (in cm3/100 mol) that can be calculated for any solute simply from molecular structure using a table of atomic constants. It was found that the relative constants of the solvation equation were very similar for the CHIIAM and for the log kIAM. The IAM lipophilicity scale was quite similar to the octanol/water lipophilicity scale for neutral compounds. The effect of charge on the interaction with IAM was studied by varying the mobile phase pH. © 2000 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 89: 1085–1096, 2000
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
